Purchases and Sales Made in Q4 2024 in Abbott Laboratories (ABT)
This table provides information about the institutional ownership of Abbott Laboratories (ABT) during Q4 2024. The information is specifically focused on institutions that hold shares of ABBOTT LABORATORIES.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 13, 2025
Q4 2024
|
Barclays PLC
London, X0 |
SELL
|
- |
-1.85M- 41.79% |
$207M - $220M
|
2.57M
$347M
|
|
|
Jan 23, 2025
Q4 2024
|
Strategic Wealth Investment Group, LLC
|
SELL
|
- |
-2.13M- 99.91% |
$239M - $255M
|
1.82K
$246K
|
|
|
Feb 12, 2025
Q4 2024
|
Arrowstreet Capital, Limited Partnership
Boston, MA |
SELL
|
- |
-2.3M- 90.9% |
$257M - $275M
|
230K
$31M
|
|
|
Feb 14, 2025
Q4 2024
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
SELL
|
- |
-2.52M- 64.35% |
$282M - $300M
|
1.39M
$188M
|
|
|
Feb 13, 2025
Q4 2024
|
Legal & General Group PLC
London, X0 |
SELL
|
- |
-2.73M- 19.13% |
$305M - $326M
|
11.5M
$1.56B
|